Stocks Under Consideration: Penn National Gaming, Inc (NASDAQ:PENN), Fossil Group Inc (NASDAQ:FOSL), Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

On Friday, Shares of Penn National Gaming, Inc (NASDAQ:PENN), added 3.16% and closed at $13.40 in the last trading session. The last trading range of the stock ranges between $12.92 and $13.46. Gaming and Leisure Properties, Inc. (GLPI) (the “Company”), the first gaming-focused REIT in North America, recently declared results for the quarter ended September 30, 2016.

(1) The guidance figures in the tables above present the guidance offered on August 9, 2016, for the three months ended September 30, 2016.

(2) Funds from operations (“FFO”) is net income, apart from (gains) or losses from sales of property and real estate depreciation as defined by NAREIT.

(3) Adjusted funds from operations (“AFFO”) is FFO, apart from stock based compensation expense, debt issuance costs amortization, other depreciation, amortization of land rights, straight-line rent adjustments and direct financing lease adjustments, reduced by capital maintenance expenditures.

(4) Adjusted EBITDA is net income apart from interest, taxes on income, depreciation, (gains) or losses from sales of property, stock based compensation expense, straight-line rent adjustments, direct financing lease adjustments and the amortization of land rights.

Fossil Group Inc (NASDAQ:FOSL), jumped 1.76% and closed at $31.74 in the last trading session. The last trading range of the stock ranges between $31.14 and $31.95. The company’s Market capitalization is $1.55 Billion with the total Outstanding Shares of 48.13 million.

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), jumped 0.37% and closed at $13.65 in the last trading session. The last trading range of the stock ranges between $13.23 and $13.70.The company stock’s 52-week range is $7.86 – $18.85. Momenta Pharmaceuticals, Inc. (MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, recently declared the appointment of Scott M. Storer as Senior Vice President and Chief Financial Officer. Mr. Storer is expected to begin at Momenta on November 28, 2016 and will replace Momenta’s current Chief Financial Officer, Rick Shea, who will be retiring. Mr. Storer will report directly to Craig Wheeler, Momenta’s President and Chief Executive Officer, and will serve as a member of the Executive Committee.

“I am very happy to have Scott join Momenta. He has a great track record across his 20 years with Baxter and Baxalta, and I believe his expertise in financial planning and leading global planned growth programs and operations will benefit Momenta tremendously,” said Craig Wheeler, President and CEO, Momenta Pharmaceuticals. “With the addition of Scott’s leadership, I look forward to continuing to advance the development and commercialization of our robust portfolio of biosimilar and novel drug candidates.”

Leave a Reply

Your email address will not be published. Required fields are marked *